A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: Immunological characterization

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Jarius, Sven ^a   Wandinger, Klaus P ^b,c   Horn, Sigrun ^d   Heuer, Heike ^d   Wildemann, Brigitte ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Institute of Experimental Immunology   (Germany)

^d FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CALBINDIN; COMPLEMENT COMPONENT C3B; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M; LORAZEPAM; METHYLPREDNISOLONE; RHO GUANINE TRIPHOSPHATASE ACTIVATING PROTEIN 26; UNCLASSIFIED DRUG; ARHGAP26 PROTEIN, HUMAN; GLIAL FIBRILLARY ACIDIC PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PARVALBUMIN; TUMOR ANTIGEN;

ADULT; ANIMAL TISSUE; ANXIETY; ARTICLE; CASE REPORT; CELLULAR DISTRIBUTION; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CEREBROSPINAL FLUID ANALYSIS; COMMON COLD; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DEPRESSION; DIPLOPIA; DRUG DOSE REDUCTION; DYSARTHRIA; FEMALE; GAIT DISORDER; HUMAN; HYPEREKPLEXIA; IMMUNOADSORPTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INSOMNIA; MOUSE; NONHUMAN; NYSTAGMUS; OSCILLOPSIA; PLASMAPHERESIS; PURKINJE CELL; RAT; RESTLESSNESS; RHESUS MONKEY; RIGHT HEMISPHERE; SLURRED SPEECH; SUICIDAL IDEATION; WESTERN BLOTTING; WHITE MATTER; ANIMAL; CELL CULTURE; CEREBELLUM; CYTOLOGY; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOLECULAR WEIGHT; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROTEIN MICROARRAY;

ADULT; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELLS, CULTURED; CEREBELLAR ATAXIA; CEREBELLUM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GTPASE-ACTIVATING PROTEINS; HUMANS; IMMUNOGLOBULIN G; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR WEIGHT; PARVALBUMINS; PROTEIN ARRAY ANALYSIS; PURKINJE CELLS;

EID: 77949464892     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-21     Document Type: Article

References (53)

1. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuuren JJ, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004, 75:1135-1140. 10.1136/jnnp.2003.034447, 1739186, 15258215.
2. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 2002, 1:294-305. 10.1016/S1474-4422(02)00135-7, 12849427.
3. Graus F, Keime-Guibert F, Rene R, Benyahia B, Ribalta T, Ascaso C, Escaramis G, Delattre JY. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001, 124:1138-1148. 10.1093/brain/124.6.1138, 11353730.
4. Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992, 42:1931-1937.
5. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001, 49:146-154. 10.1002/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E, 11220734.
6. Honnorat J, Antoine JC, Belin MF. Are the "newly discovered" paraneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies?. Ann Neurol 2001, 50:688-691. 10.1002/ana.1270, 11706981.
7. Trotter JL, Hendin BA, Osterland CK. Cerebellar degeneration with Hodgkin disease. An immunological study. Arch Neurol 1976, 33:660-661.
8. Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR, Dalmau J. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 2004, 62:778-782. 2574539, 15007130.
9. Sabater L, Bataller L, Carpentier AF, Aguirre-Cruz ML, Saiz A, Benyahia B, Dalmau J, Graus F. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J Neurol Neurosurg Psychiatry 2006, 77:1359-1362. 10.1136/jnnp.2006.097188, 2077410,2077410, 16801349.
10. Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, Henzen-Logmans S, Vecht C, De Zeeuw C, Sekiyama N, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 2000, 342:21-27. 10.1056/NEJM200001063420104, 10620645.
11. Coesmans M, Smitt PA, Linden DJ, Shigemoto R, Hirano T, Yamakawa Y, van Alphen AM, Luo C, Geest JN, Kros JM, et al. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies. Ann Neurol 2003, 53:325-336. 10.1002/ana.10451, 12601700.
12. Vernino S, Lennon VA. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 2000, 47:297-305. 10.1002/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4, 10716248.
13. Chan KH, Vernino S, Lennon VA. ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 2001, 50:301-311. 10.1002/ana.1127, 11558786.
14. Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 2002, 59:764-766.
15. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001, 58:225-230. 10.1001/archneur.58.2.225, 11176960.
16. Rakocevic G, Raju R, Semino-Mora C, Dalakas MC. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology 2006, 67:1068-1070. 10.1212/01.wnl.0000237558.83349.d0, 17000981.
17. Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 2008, 64:332-343. 10.1002/ana.21450, 18825674.
18. Shiihara T, Kato M, Konno A, Takahashi Y, Hayasaka K. Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody. Brain Dev 2007, 29:254-256. 10.1016/j.braindev.2006.09.004, 17049194.
19. Shimokaze T, Kato M, Yoshimura Y, Takahashi Y, Hayasaka K. A case of acute cerebellitis accompanied by autoantibodies against glutamate receptor delta2. Brain Dev 2007, 29:224-226. 10.1016/j.braindev.2006.08.011, 17008044.
20. Zuliani L, Sabater L, Saiz A, Baiges JJ, Giometto B, Graus F. Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia. Neurology 2007, 68:239-240. 10.1212/01.wnl.0000251308.79366.f9, 17224583.
21. Reiber H. Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 1998, 4:99-107.
22. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991, 37:1153-1160.
23. Baptista CA, Hatten ME, Blazeski R, Mason CA. Cell-cell interactions influence survival and differentiation of purified Purkinje cells in vitro. Neuron 1994, 12:243-260. 10.1016/0896-6273(94)90268-2, 8110456.
24. Hatten ME, Gao W, Morrison ME, Mason CA. The cerebellum: purification and coculture of identified cell populations. Culturing nerve cells 1998, 419-458. Cambridge, Massachusetts: The MIT Press, Banker G, Goslin K.
25. Graus F, Dalmau J, Valldeoriola F, Ferrer I, Rene R, Marin C, Vecht CJ, Arbizu T, Targa C, Moll JW. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997, 74:55-61. 10.1016/S0165-5728(96)00205-6, 9119979.
26. Sillevis Smitt P. Paraneoplastic neurological syndromes. Lancet Neurol 2002, 1:408. 10.1016/S1474-4422(02)00218-1, 12849362.
27. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 2008, 7:939-950. 10.1016/S1474-4422(08)70215-1, 18848313.
28. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985, 1:1313-1315. 10.1016/S0140-6736(85)92801-6, 2860501.
29. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53:1107-1114.
30. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 2004, 251:47-52. 10.1007/s00415-004-0271-0, 14999489.
31. Bakker MJ, van Dijk JG, Maagdenberg AM, Tijssen MA. Startle syndromes. Lancet Neurol 2006, 5:513-524. 10.1016/S1474-4422(06)70470-7, 16713923.
32. Goraya JS, Shah D, Poddar B. Hyperekplexia in a girl with posterior fossa malformations. J Child Neurol 2002, 17:147-149. 10.1177/088307380201700213, 11952078.
33. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, Geraldes R, Vale T, Jacob A, Palace J, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008, 65:913-919. 10.1001/archneur.65.7.913, 18625857.
34. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:2221-2231. 10.1212/01.WNL.0000289761.64862.ce, 17928579.
35. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B. Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008, 4:202-214.
36. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, Hohlfeld R, Vincent A. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007, 68:1076-1077. 10.1212/01.wnl.0000256822.01222.bd, 17287449.
37. Vincent A, Lang B, Newsom-Davis J. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 1989, 12:496-502. 10.1016/0166-2236(89)90109-4, 2480664.
38. Graus F, Illa I, Agusti M, Ribalta T, Cruz-Sanchez F, Juarez C. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci 1991, 106:82-87. 10.1016/0022-510X(91)90198-G, 1779243.
39. Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin Neurol Neurosurg 1995, 97:101-105. 10.1016/0303-8467(95)00006-6, 7788964.
40. Tanaka K, Tanaka M, Onodera O, Igarashi S, Miyatake T, Tsuji S. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J Neurol Sci 1994, 127:153-158. 10.1016/0022-510X(94)90067-1, 7707074.
41. Tanaka M, Maruyama Y, Sugie M, Motizuki H, Kamakura K, Tanaka K. Cytotoxic T cell activity against peptides of Hu protein in anti-Hu syndrome. J Neurol Sci 2002, 201:9-12. 10.1016/S0022-510X(02)00157-0, 12163187.
42. Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 1999, 45:162-167. 10.1002/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R, 9989617.
43. Rousseau A, Benyahia B, Dalmau J, Connan F, Guillet JG, Delattre JY, Choppin J. T cell response to Hu-D peptides in patients with anti-Hu syndrome. J Neurooncol 2005, 71:231-236. 10.1007/s11060-004-1723-1, 2586925, 15735910.
44. Voltz R, Dalmau J, Posner JB, Rosenfeld MR. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 1998, 51:1146-1150.
45. Sommer C, Weishaupt A, Brinkhoff J, Biko L, Wessig C, Gold R, Toyka KV. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 2005, 365:1406-1411. 10.1016/S0140-6736(05)66376-3, 15836889.
46. Lundmark R, Doherty GJ, Howes MT, Cortese K, Vallis Y, Parton RG, McMahon HT. The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway. Curr Biol 2008, 18:1802-1808. 10.1016/j.cub.2008.10.044, 2726289, 19036340.
47. Grabs D, Slepnev VI, Songyang Z, David C, Lynch M, Cantley LC, De Camilli P. The SH3 domain of amphiphysin binds the proline-rich domain of dynamin at a single site that defines a new SH3 binding consensus sequence. J Biol Chem 1997, 272:13419-13425. 10.1074/jbc.272.20.13419, 9148966.
48. Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol 2002, 132:72-82. 10.1016/S0165-5728(02)00314-4, 12417436.
49. Golan TD, Gharavi AE, Elkon KB. Penetration of autoantibodies into living epithelial cells. J Invest Dermatol 1993, 100:316-322. 10.1111/1523-1747.ep12469994, 8440912.
50. Zack DJ, Stempniak M, Wong AL, Taylor C, Weisbart RH. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J Immunol 1996, 157:2082-2088.
51. Yanase K, Smith RM, Puccetti A, Jarett L, Madaio MP. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest 1997, 100:25-31. 10.1172/JCI119517, 508161, 9202053.
52. Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE. Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation 2009, 6:31. 10.1186/1742-2094-6-31, 2775726, 19874605.
53. Borkhardt A, Bojesen S, Haas OA, Fuchs U, Bartelheimer D, Loncarevic IF, Bohle RM, Harbott J, Repp R, Jaeger U, et al. The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. Proc Natl Acad Sci USA 2000, 97:9168-9173. 10.1073/pnas.150079597, 16840, 10908648.